Longitudinal ctDNA analysis by combined targeted NGS and sWGS-based CNA profiling
To evaluate response to combined ICI therapy, we longitudinally collected plasma samples upon enrollment (baseline) and in three-monthly intervals (follow-up) to analyze ccfDNA and its tumor-derived ctDNA fraction (Fig. 